Over the past 8 years in the pharmaceutical industry, I have developed various highly technical skills in analytical chemistry and early-phase drug development. I'm currently leveraging this experience to provide preclinical & development support for early portfolio small molecule & peptide compounds heading through development candidate selection and into Phase 1 trials. This includes support drafting regulatory submission documents, pre/clinical study support, site selection and general Phase 1 strategy.Analytical skills utilized throughout my experience include: Analysis by H/UPLC and UV/Vis Spectrophotometry, Dissolution, Karl Fischer, TGA, DSC, PXRD, formulation development, stability studies, data trending, investigative analysis, and generating SDS’s and CoA’s.Throughout this journey, I’ve been able to continue pursuing my passion for drug development, while also benefitting lives of millions through improved access to revolutionary medications for both existing and emergent health conditions.